Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous hematopoietic stem cells (1 trial)
busulfan (Myleran) (1 trial)
cytarabine (cytosar-u) (1 trial)
etoposide (vepesid) (1 trial)
hydroxyurea (hydrea) (1 trial)
idarubicin (idamycin) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
sargramostim (leukine) (1 trial)
Leukemia (Phase 3)
Trials (1 total)
Trial APIs (8 total)